ESMO World Congress on Gastrointestinal Cancer 2016

Oncology Meeting Resources

29 Jun - 02 Jul 2016, Barcelona, Spain

World GI 2016 Square Image

The ESMO World Congress on Gastrointestinal Cancer is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.

Abstracts, presentations and webcasts from the ESMO World GI 2016 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.





Format available

http://oncologypro.esmo.org/Meeting-Resourc...ody-Mass-Index-in-colorectal-cancer-patients

Depletion of skeletal muscle (sarcopenia) and, hence, of overall Lean Body Mass (LBM) has been associated with poor performance status, chemotherapy toxicity, and shortened survival in cancer patients,...

Date: 29 Jun 2016
Presenter: V. Alivizatos
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...ence-and-sensitivity-to-MET-inhibitor-AMG337

Activation of the MET oncogene can result from amplification or activating mutation. MET mutations affecting the 14 5' splice acceptor site or the 3' splice donor site cause in-frame skipping of exon 14.

Date: 29 Jun 2016
Presenter: F. Cecchi
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...ors-hemostasis-system-and-adjuvant-treatment

This study aimed to determine homeostasis and tumor factors for 5-year survival (5YS) of gastric cancer (GC) patients (GCP) (T1-4N0-2M0) after complete en block (R0) gastrectomies and D2-4 lymph node dissections.

Date: 29 Jun 2016
Presenter: O. Kshivets
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...tients-with-Gastrointestinal-GI-Malignancies

Fluoropyrimidines (5-Fluorouracil, Capecitabine and Tegafur) are antimetabolites that target the S phase of the cell cycle. The active metabolite, 5-fluorodeoxyuridine monophosphate inhibits TYMS, thus...

Date: 29 Jun 2016
Presenter: M. Khushman
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...c-marker-in-pancreatic-ductal-adenocarcinoma

Pancreatic ductal adenocarcinoma (PADC) is one of the principal causes of cancer-related death worldwide. New therapeutic options against PADC had limited success.

Date: 29 Jun 2016
Presenter: M. Cruz Ramos
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...tion-in-resection-of-advanced-gastric-cancer

With the increasing popularity and application of laparoscopic approach in gastric cancer treatment, indications for laparoscopic gastrectomy (LG) have been broader.

Date: 29 Jun 2016
Presenter: B. Castro
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...lori-in-development-of-stomach-MALT-lymphoma

The discovery of H. Pylori and the proof of its leading role in the development of most of gastrointestinal diseases has radically changed the approach to their treatment.

Date: 29 Jun 2016
Presenter: M. Mallaev
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...of-large-right-lobe-hepatocellular-carcinoma

Hepatocellular carcinoma (HCC) accounts for 80%-90% of primary liver cancer and is a global health problem. Hepatic resection remains the mainstay in the treatment for HCC with potential cure.

Date: 29 Jun 2016
Presenter: H. Fakhry
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...pective-study-with-propensity-score-analysis

There is a known over morbidity for cirrhotic patients operated for malignant tumor. The aim of this study was to compare the laparoscopic approach and open surgery for minor resection for colorectal...

Date: 29 Jun 2016
Presenter: F. Le Roux
Resources: Abstract

http://oncologypro.esmo.org/Meeting-Resourc...nduction-of-M2-macrophages-in-gastric-cancer

Tumor-associated macrophages of the M2 phenotype promote tumor proliferation and are associated with a poor prognosis in patients with various malignancies. We previously reported that large numbers...

Date: 29 Jun 2016
Presenter: T. Yamaguchi
Resources: Abstract